Linq Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 9 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 17.28%
- Profit Growth -19.03%
- Ebitda 31.69%
- Net Worth 99.18%
- Total Assets -17.36%
About Linq Therapeutics
Linq Therapeutics Private Limited (LTPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 September 2015 (Nine years and seven months 4 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Jehangir Jehangir, Uma Divate, Pathik Divate, and Two other members serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74999PN2015PTC156595
- Company No.
156595
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Sep 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Healthcare
Linq Therapeutics Private Limited
Explore comprehensive data for Linq Therapeutics Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Linq Therapeutics?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Uma Divate  | Director | 29-Sep-2015 | Current |
| Pathik Divate | Director | 29-Sep-2015 | Current |
| Cowasji Jehangir | Director | 25-Nov-2020 | Current |
| Jehangir Jehangir | Director | 29-Sep-2015 | Current |
| Geeta Divate | Director | 25-Nov-2020 | Current |
Financial Performance of Linq Therapeutics.
Linq Therapeutics Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 17.28% increase. The company also saw a substantial fall in profitability, with a 19.03% decrease in profit. The company's net worth Soared by an impressive increase of 99.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Linq Therapeutics?
In 2019, Linq Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Hindustan Hardy LimitedCowasji Jehangir is a mutual person
Bharat Bijlee LimitedJehangir Jehangir is a mutual person
Chowgule Industries Private LimitedJehangir Jehangir is a mutual person
Ananta Landwise Private LimitedJehangir Jehangir is a mutual person
Goodearth Enterprises LlpJehangir Jehangir is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Linq Therapeutics?
Linq Therapeutics has a workforce of 5 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Linq Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Linq Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Linq Therapeutics
Recent activity within the organization
- Annual General Meeting
Linq Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Linq Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune.
- Director Appointment
Cowasji Jehangir Jehangir was appointed as a Director was appointed as a Director on 25 Nov 2020 & has been associated with this company since 4 years 5 months .
- Director Appointment
Geeta Pathik Divate was appointed as a Director was appointed as a Director on 25 Nov 2020 & has been associated with this company since 4 years 5 months .
- Director Appointment
Jehangir Hirji Cawasji Jehangir was appointed as a Director was appointed as a Director on 29 Sep 2015 & has been associated with this company since 9 years 7 months .
- Director Appointment
Uma Pradeep Divate was appointed as a Director was appointed as a Director on 29 Sep 2015 & has been associated with this company since 9 years 7 months .
Frequently asked questions
What is the Incorporation or founding date of Linq Therapeutics Private Limited?
Linq Therapeutics Private Limited was incorporated on 29 Sep 2015.
What is authorized share capital and paid-up capital of Linq Therapeutics Private Limited?
The authorized share capital of Linq Therapeutics Private Limited is ₹ 5.00 M and paid-up capital is ₹ 5.00 M.
Who are the current board members & directors of Linq Therapeutics Private Limited?
Currently 5 directors are associated with Linq Therapeutics Private Limited.
- Jehangir Hirji Cawasji Jehangir
- Uma Pradeep Divate
- Pathik Pradeep Divate
- Cowasji Jehangir Jehangir
- Geeta Pathik Divate
What is the registered address of Linq Therapeutics Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Linq Therapeutics Private Limited is 324 M.G. Road Taboot Street, Camp India, Pune, Maharashtra, 411001.
What is the corporate identification number (CIN) and company number of Linq Therapeutics Private Limited?
The corporate identification number (CIN) of Linq Therapeutics Private Limited is U74999PN2015PTC156595 and the company number is 156595 as per Ministry of Corporate Affairs (MCA).
What is the official website of Linq Therapeutics Private Limited?
The Official website of Linq Therapeutics Private Limited is https://www.linqlabs.com
What has been the recent revenue trend for Linq Therapeutics Private Limited?
According to the financial reports for the fiscal year 2022, the revenue trend for Linq Therapeutics Private Limited has risen by 17.28%.
How many employees does Linq Therapeutics Private Limited currently have?
As Per 2022 financial reports, 5 employees are currently employed by Linq Therapeutics Private Limited.
What change has been observed in the net worth of Linq Therapeutics Private Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Linq Therapeutics Private Limited has experienced an upsurge of 99.18%.
When was the last Balance Sheet of Linq Therapeutics Private Limited filed with the ROC?
The most recent Balance Sheet for Linq Therapeutics Private Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records